McKesson's Compounding Keeps Adding UpCardinal Health (NYSE:CAH) reported fourth-quarter fiscal 2026 results marked by growth in revenue, operating earnings and adjusted earnings per share, supported by demand in its pharmaceutical and specialty businesses and a one-time tariff-related benefit in its medical products segment. Fiscal 2026 Results and Capital DeploymentFor the full fiscal year, Cardinal Health said revenue grew 14% to $254 billion, while gross margin increased 20% to $9.8 billion. Operating earnings rose 30% to $3.6 billion. Cardinal Health invested $649 million in capital expenditures during the year, including investments in automation, supply-chain technology, customer solutions and platform capabilities. Fiscal 2026 share repurchases: $1.35 billion.